Theranos to appeal regulatory sanctions on its lab

(Reuters) – Blood-testing company Theranos Inc said it plans to appeal the sanctions imposed by a U.S. regulator last month on one of its labs alleging its practices jeopardized patient health and safety.

(Reuters) – Blood-testing company Theranos Inc said it plans to appeal the sanctions imposed by a U.S. regulator last month on one of its labs alleging its practices jeopardized patient health and safety.
Original Article